English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
30 June 2014 - FDA approves the registration of Enoxaparine

The manufacturing is started at the Italfarmaco manufacturing plant of Milan

FDA approves the registration of Enoxaparine for Teva Co., business partner of Chemi, a company belonging to Italfarmaco Group and specialized in the development and characterization of complex molecules, with manufacturing potential including both the active ingredient synthesis and the manufacturing of the new pharmaceutical form of preparations for injections.